UK body rejects Novartis drug

Novartis’s multiple sclerosis pill Gilenya failed for a second time to gain the backing of the UK’s health-cost agency, denting the company’s ambitions to turn the drug into a blockbuster. (Times) >

About these ads
Tagged with:
Posted in Medicines, Pharmaceutical

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s

Need help with a writing task?

Email medica@penhire.ie for a quote. We'll have you right in no time.

TESTIMONIAL: "Paul was commissioned to assist with writing a lay summary of a research grant proposal for a piece of laboratory equipment. He phrased advanced science concepts in a way that could be easily understood, and which was a pleasure to read."

Sign up to our email alert so you don’t miss anything >
Categories
Follow

Get every new post delivered to your Inbox.

Join 296 other followers

%d bloggers like this: